annual EBIT:
-$580.11M-$391.94M(-208.30%)Summary
- As of today (September 10, 2025), ARWR annual earnings before interest & taxes is -$580.11 million, with the most recent change of -$391.94 million (-208.30%) on September 30, 2024.
- During the last 3 years, ARWR annual EBIT has fallen by -$439.26 million (-311.87%).
- ARWR annual EBIT is now -1048.03% below its all-time high of $61.19 million, reached on September 30, 2019.
Performance
ARWR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$165.55M-$546.75M(-143.43%)Summary
- As of today (September 10, 2025), ARWR quarterly earnings before interest & taxes is -$165.55 million, with the most recent change of -$546.75 million (-143.43%) on June 30, 2025.
- Over the past year, ARWR quarterly EBIT has increased by +$10.59 million (+6.01%).
- ARWR quarterly EBIT is now -143.43% below its all-time high of $381.20 million, reached on March 31, 2025.
Performance
ARWR quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$107.96M+$10.59M(+8.93%)Summary
- As of today (September 10, 2025), ARWR TTM earnings before interest & taxes is -$107.96 million, with the most recent change of +$10.59 million (+8.93%) on June 30, 2025.
- Over the past year, ARWR TTM EBIT has increased by +$439.24 million (+80.27%).
- ARWR TTM EBIT is now -276.44% below its all-time high of $61.19 million, reached on September 30, 2019.
Performance
ARWR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ARWR EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -208.3% | +6.0% | +80.3% |
| 3 y3 years | -311.9% | -127.1% | +32.3% |
| 5 y5 years | -1048.0% | -938.2% | -223.2% |
ARWR EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -311.9% | at low | -143.4% | +6.0% | at high | +82.8% |
| 5 y | 5-year | -1048.0% | at low | -143.4% | +6.0% | -223.2% | +82.8% |
| alltime | all time | -1048.0% | at low | -143.4% | +6.0% | -276.4% | +82.8% |
ARWR EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$165.55M(-143.4%) | -$107.96M(-8.9%) |
| Mar 2025 | - | $381.20M(-336.2%) | -$118.55M(-81.1%) |
| Dec 2024 | - | -$161.41M(-0.5%) | -$625.95M(+4.1%) |
| Sep 2024 | -$580.11M(+208.3%) | -$162.20M(-7.9%) | -$601.08M(+9.8%) |
| Jun 2024 | - | -$176.14M(+39.6%) | -$547.21M(+15.5%) |
| Mar 2024 | - | -$126.19M(-7.6%) | -$473.77M(+58.2%) |
| Dec 2023 | - | -$136.54M(+26.0%) | -$299.41M(+46.1%) |
| Sep 2023 | -$188.16M(+8.9%) | -$108.33M(+5.5%) | -$205.00M(+13.6%) |
| Jun 2023 | - | -$102.70M(-313.2%) | -$180.50M(+19.8%) |
| Mar 2023 | - | $48.16M(-214.3%) | -$150.71M(-4.2%) |
| Dec 2022 | - | -$42.13M(-49.7%) | -$157.32M(-11.9%) |
| Sep 2022 | -$172.71M(+22.6%) | -$83.83M(+15.0%) | -$178.51M(+11.9%) |
| Jun 2022 | - | -$72.91M(-275.5%) | -$159.56M(+34.6%) |
| Mar 2022 | - | $41.55M(-165.6%) | -$118.52M(-37.1%) |
| Dec 2021 | - | -$63.32M(-2.4%) | -$188.30M(+26.3%) |
| Sep 2021 | -$140.85M(+51.2%) | -$64.88M(+103.6%) | -$149.04M(+11.0%) |
| Jun 2021 | - | -$31.87M(+12.9%) | -$134.27M(+13.5%) |
| Mar 2021 | - | -$28.23M(+17.4%) | -$118.35M(+5.3%) |
| Dec 2020 | - | -$24.05M(-52.0%) | -$112.36M(+20.6%) |
| Sep 2020 | -$93.16M(-252.2%) | -$50.12M(+214.3%) | -$93.16M(+178.9%) |
| Jun 2020 | - | -$15.95M(-28.3%) | -$33.40M(-3030.2%) |
| Mar 2020 | - | -$22.24M(+358.2%) | $1.14M(-97.5%) |
| Dec 2019 | - | -$4.85M(-150.4%) | $45.39M(-25.8%) |
| Sep 2019 | $61.19M(-209.4%) | $9.64M(-48.2%) | $61.19M(+51.5%) |
| Jun 2019 | - | $18.60M(-15.5%) | $40.38M(+588.2%) |
| Mar 2019 | - | $22.01M(+101.1%) | $5.87M(-118.8%) |
| Dec 2018 | - | $10.95M(-198.0%) | -$31.18M(-44.3%) |
| Sep 2018 | -$55.94M(+51.2%) | -$11.17M(-29.8%) | -$55.94M(+1.7%) |
| Jun 2018 | - | -$15.92M(+5.9%) | -$55.02M(+22.8%) |
| Mar 2018 | - | -$15.03M(+8.8%) | -$44.81M(+24.8%) |
| Dec 2017 | - | -$13.81M(+34.8%) | -$35.91M(-2.9%) |
| Sep 2017 | -$37.00M(-53.6%) | -$10.25M(+79.4%) | -$37.00M(-29.3%) |
| Jun 2017 | - | -$5.71M(-6.8%) | -$52.35M(-20.7%) |
| Mar 2017 | - | -$6.13M(-58.9%) | -$65.98M(-18.7%) |
| Dec 2016 | - | -$14.90M(-41.8%) | -$81.12M(-5.2%) |
| Sep 2016 | -$79.69M(-17.0%) | -$25.61M(+32.4%) | -$85.55M(+2.7%) |
| Jun 2016 | - | -$19.34M(-9.0%) | -$83.29M(+4.2%) |
| Mar 2016 | - | -$21.26M(+9.9%) | -$79.94M(+2.3%) |
| Dec 2015 | - | -$19.34M(-17.1%) | -$78.16M(-6.9%) |
| Sep 2015 | -$95.97M(+87.8%) | -$23.34M(+45.9%) | -$83.94M(+7.1%) |
| Jun 2015 | - | -$15.99M(-17.9%) | -$78.41M(+4.4%) |
| Mar 2015 | - | -$19.49M(-22.4%) | -$75.11M(+12.4%) |
| Dec 2014 | - | -$25.12M(+41.0%) | -$66.83M(+37.2%) |
| Sep 2014 | -$51.10M(+119.5%) | -$17.81M(+40.2%) | -$48.73M(+29.9%) |
| Jun 2014 | - | -$12.70M(+13.3%) | -$37.50M(+25.5%) |
| Mar 2014 | - | -$11.21M(+60.0%) | -$29.88M(+24.2%) |
| Dec 2013 | - | -$7.01M(+6.6%) | -$24.06M(+10.1%) |
| Sep 2013 | -$23.28M(+10.4%) | -$6.58M(+29.4%) | -$21.86M(+5.8%) |
| Jun 2013 | - | -$5.08M(-5.7%) | -$20.66M(-7.7%) |
| Mar 2013 | - | -$5.39M(+12.1%) | -$22.38M(+2.4%) |
| Dec 2012 | - | -$4.81M(-10.6%) | -$21.86M(+3.7%) |
| Sep 2012 | -$21.09M | -$5.38M(-20.9%) | -$21.09M(+13.2%) |
| Jun 2012 | - | -$6.80M(+39.7%) | -$18.62M(+37.0%) |
| Mar 2012 | - | -$4.87M(+20.5%) | -$13.59M(+29.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | - | -$4.04M(+38.7%) | -$10.53M(+40.4%) |
| Sep 2011 | -$9.83M(+68.5%) | -$2.91M(+64.5%) | -$7.50M(+8.1%) |
| Jun 2011 | - | -$1.77M(-2.3%) | -$6.94M(-5.4%) |
| Mar 2011 | - | -$1.81M(+79.5%) | -$7.33M(-4.2%) |
| Dec 2010 | - | -$1.01M(-57.0%) | -$7.65M(-13.1%) |
| Sep 2010 | -$5.83M(-70.2%) | -$2.35M(+8.5%) | -$8.80M(-9.8%) |
| Jun 2010 | - | -$2.16M(+1.6%) | -$9.76M(-1.6%) |
| Mar 2010 | - | -$2.13M(-1.4%) | -$9.92M(-11.5%) |
| Dec 2009 | - | -$2.16M(-34.7%) | -$11.21M(-21.7%) |
| Sep 2009 | -$19.56M(-44.1%) | -$3.31M(+42.3%) | -$14.32M(-36.6%) |
| Jun 2009 | - | -$2.32M(-32.0%) | -$22.57M(-25.1%) |
| Mar 2009 | - | -$3.42M(-35.2%) | -$30.15M(-10.8%) |
| Dec 2008 | - | -$5.27M(-54.4%) | -$33.80M(-4.5%) |
| Sep 2008 | -$35.00M(-7.8%) | -$11.56M(+16.8%) | -$35.41M(-0.2%) |
| Jun 2008 | - | -$9.90M(+39.9%) | -$35.50M(-9.0%) |
| Mar 2008 | - | -$7.07M(+2.7%) | -$39.00M(-3.4%) |
| Dec 2007 | - | -$6.89M(-40.9%) | -$40.36M(+6.4%) |
| Sep 2007 | -$37.95M(+85.3%) | -$11.64M(-13.1%) | -$37.95M(+11.4%) |
| Jun 2007 | - | -$13.40M(+58.9%) | -$34.06M(+35.4%) |
| Mar 2007 | - | -$8.43M(+88.5%) | -$25.15M(+21.7%) |
| Dec 2006 | - | -$4.47M(-42.4%) | -$20.66M(+2.1%) |
| Sep 2006 | -$20.48M(+113.5%) | -$7.76M(+73.1%) | -$20.24M(+40.8%) |
| Jun 2006 | - | -$4.48M(+13.6%) | -$14.37M(+8.5%) |
| Mar 2006 | - | -$3.95M(-2.7%) | -$13.25M(+17.2%) |
| Dec 2005 | - | -$4.05M(+114.0%) | -$11.30M(+22.9%) |
| Sep 2005 | -$9.59M(+256.5%) | -$1.89M(-43.6%) | -$9.20M(+4.5%) |
| Jun 2005 | - | -$3.36M(+67.7%) | -$8.80M(+45.7%) |
| Mar 2005 | - | -$2.00M(+2.9%) | -$6.04M(+32.2%) |
| Dec 2004 | - | -$1.94M(+29.8%) | -$4.57M(+65.1%) |
| Sep 2004 | -$2.69M(+2750.4%) | -$1.50M(+151.4%) | -$2.77M(+115.0%) |
| Jun 2004 | - | -$596.00K(+12.1%) | -$1.29M(+82.2%) |
| Mar 2004 | - | -$531.50K(+273.0%) | -$706.70K(+245.2%) |
| Dec 2003 | - | -$142.50K(+709.7%) | -$204.70K(+116.6%) |
| Sep 2003 | -$94.40K(-93.3%) | -$17.60K(+16.6%) | -$94.50K(+22.9%) |
| Jun 2003 | - | -$15.10K(-48.8%) | -$76.90K(-30.5%) |
| Mar 2003 | - | -$29.50K(-8.7%) | -$110.70K(+6.9%) |
| Dec 2002 | - | -$32.30K(<-9900.0%) | -$103.60K(+6.8%) |
| Sep 2002 | -$1.42M(+1232.3%) | $0.00(-100.0%) | -$97.00K(0.0%) |
| Jun 2002 | - | -$48.90K(+118.3%) | -$97.00K(+52.5%) |
| Mar 2002 | - | -$22.40K(-12.8%) | -$63.60K(-4.6%) |
| Dec 2001 | - | -$25.70K(<-9900.0%) | -$66.70K(-12.7%) |
| Sep 2001 | -$106.30K(-2.7%) | $0.00(-100.0%) | -$76.40K(-26.6%) |
| Jun 2001 | - | -$15.50K(-39.2%) | -$104.10K(-6.9%) |
| Mar 2001 | - | -$25.50K(-28.0%) | -$111.80K(0.0%) |
| Dec 2000 | - | -$35.40K(+27.8%) | -$111.80K(+2.3%) |
| Sep 2000 | -$109.20K(+94.3%) | -$27.70K(+19.4%) | -$109.30K(+30.7%) |
| Jun 2000 | - | -$23.20K(-9.0%) | -$83.60K(+6.4%) |
| Mar 2000 | - | -$25.50K(-22.5%) | -$78.60K(+14.1%) |
| Dec 1999 | - | -$32.90K(+1545.0%) | -$68.90K(+91.4%) |
| Sep 1999 | -$56.20K(+131.3%) | -$2000.00(-89.0%) | -$36.00K(+5.9%) |
| Jun 1999 | - | -$18.20K(+15.2%) | -$34.00K(+115.2%) |
| Mar 1999 | - | -$15.80K | -$15.80K |
| Sep 1998 | -$24.30K(-84.7%) | - | - |
| Sep 1997 | -$158.60K | - | - |
FAQ
- What is Arrowhead Pharmaceuticals, Inc. annual earnings before interest & taxes?
- What is the all time high annual EBIT for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. annual EBIT year-on-year change?
- What is Arrowhead Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
- What is Arrowhead Pharmaceuticals, Inc. TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. TTM EBIT year-on-year change?
What is Arrowhead Pharmaceuticals, Inc. annual earnings before interest & taxes?
The current annual EBIT of ARWR is -$580.11M
What is the all time high annual EBIT for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is $61.19M
What is Arrowhead Pharmaceuticals, Inc. annual EBIT year-on-year change?
Over the past year, ARWR annual earnings before interest & taxes has changed by -$391.94M (-208.30%)
What is Arrowhead Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of ARWR is -$165.55M
What is the all time high quarterly EBIT for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is $381.20M
What is Arrowhead Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
Over the past year, ARWR quarterly earnings before interest & taxes has changed by +$10.59M (+6.01%)
What is Arrowhead Pharmaceuticals, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of ARWR is -$107.96M
What is the all time high TTM EBIT for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is $61.19M
What is Arrowhead Pharmaceuticals, Inc. TTM EBIT year-on-year change?
Over the past year, ARWR TTM earnings before interest & taxes has changed by +$439.24M (+80.27%)